![Amy Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 31/05/2026
Amy Simon es directora médica de Beam Therapeutics, Inc. Anteriormente, la Dra. Simon ocupó el cargo de Vicepresidenta de Desarrollo Clínico en Alnylam Pharmaceuticals, Inc. La Dra. Simon se licenció en la Universidad de Harvard y se doctoró en la Facultad de Medicina de la Universidad de Tufts.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2026 | 102.735 ( 0,1 % ) | 3 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director Técnico/Científico/I+D | 15/03/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Graduate School of Biomedical Sciences | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Graduate School of Biomedical Sciences |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
